Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative butorphanol with or without penehyclidine for butorphanol-induced sweating
ChiCTR1900026570Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology of the First Affiliated Hospital of Zhengzhou University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butorphanol and penehyclidine in adverse drug reaction (ADR) (2 arms), sponsored by Department of Anesthesiology of the First Affiliated Hospital of Zhengzhou University. Primary endpoints: Sweating occurrence and Body temperature. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
butorphanolpenehyclidine
03
Conditions
adverse drug reaction (ADR)
Beyond the preview
Go deeper on ChiCTR1900026570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026570.